Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Management of Dyslipidemia in 2024: A Case-Based Approach
By
University of Louisville
FEATURING
Dinesh Kalra
By
University of Louisville
FEATURING
Dinesh Kalra
416 views
March 7, 2024
Dinesh K. Kalra, M.D., MBA, FACC, FNLA, FSCCT, FSCMR, FAHA, FASPC, Professor of Medicine; Chief, ...
read more ↘ Division of Cardiovascular Medicine; Vice Chair for Quality; Endowed Chair in Cardiovascular Innovations; and Director of Advanced Cardiac Imaging, Lipid Clinic & Infiltrative Heart Disease Programs at the University of Louisville School of Medicine, focused on recognizing common and uncommon lipid disorders in the clinic and when to refer to a lipid specialist, learning how to use non-statin, lipid-lowering drugs in the optimization of cardiovascular risk, and appreciating new advances in the field targeting other lipid pathways such as ANGPTL3, CETP, TRLs, and inflammation that potentially offer additional avenues to reduce the risk of myocardial infarction and cardiovascular death.
↖ read less
read more ↘ Division of Cardiovascular Medicine; Vice Chair for Quality; Endowed Chair in Cardiovascular Innovations; and Director of Advanced Cardiac Imaging, Lipid Clinic & Infiltrative Heart Disease Programs at the University of Louisville School of Medicine, focused on recognizing common and uncommon lipid disorders in the clinic and when to refer to a lipid specialist, learning how to use non-statin, lipid-lowering drugs in the optimization of cardiovascular risk, and appreciating new advances in the field targeting other lipid pathways such as ANGPTL3, CETP, TRLs, and inflammation that potentially offer additional avenues to reduce the risk of myocardial infarction and cardiovascular death.
↖ read less
Comments 0
Login to view comments.
Click here to Login